{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:00:36Z","timestamp":1767999636941,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.coi.2005.07.010","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T10:08:39Z","timestamp":1123668519000},"page":"536-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Extending options for highly sensitized patients to receive a suitable kidney graft"],"prefix":"10.1016","volume":"17","author":[{"given":"Ilias IN","family":"Doxiadis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene J","family":"Duquesnoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans HJ","family":"Claas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2005.07.010_bib1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(66)92829-7","article-title":"Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells","volume":"2","author":"Kissmeyer-Nielsen","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2005.07.010_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2005.07.010_bib3_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.TP.0000103725.72023.D7","article-title":"It takes six to boogie: allocating cadaver kidneys in Eurotransplant","volume":"77","author":"Doxiadis","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib4","first-page":"185","article-title":"Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches","author":"Claas","year":"1989","journal-title":"Clin Transpl"},{"key":"10.1016\/j.coi.2005.07.010_bib5","first-page":"351","article-title":"Acceptable HLA mismatches for highly immunized patients","volume":"1","author":"Claas","year":"1999","journal-title":"Rev Immunogenet"},{"key":"10.1016\/j.coi.2005.07.010_bib6_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000129260.86766.67","article-title":"The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome","volume":"78","author":"Claas","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib7","first-page":"115","article-title":"The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant","author":"Doxiadis","year":"1998","journal-title":"Clin Transpl"},{"key":"10.1016\/j.coi.2005.07.010_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(89)91672-3","article-title":"Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation","volume":"1","author":"Palmer","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2005.07.010_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0272-6386(12)80054-0","article-title":"Extracorporeal removal of anti-HLA antibodies in transplant candidates","volume":"16","author":"Hakim","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.coi.2005.07.010_bib10_1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.TP.0000148732.26761.FA","article-title":"Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients","volume":"79","author":"Lorenz","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.TP.0000146845.93929.EC","article-title":"Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients","volume":"79","author":"Akalin","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.TP.0000144331.18842.34","article-title":"Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathy","volume":"79","author":"Akalin","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib13","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.TP.0000153297.11006.13","article-title":"Antidonor antibodies and transplantation: how to deal with them before and after transplantation","volume":"79","author":"Glotz","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-2277.2004.tb00376.x","article-title":"Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies","volume":"17","author":"Glotz","year":"2004","journal-title":"Transpl Int"},{"key":"10.1016\/j.coi.2005.07.010_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1600-6143.2002.20801.x","article-title":"Management of the highly HLA- sensitized patient. A novel role for intravenous gammaglobulin","volume":"2","author":"Jordan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib17","first-page":"193","article-title":"Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience","author":"Jordan","year":"2003","journal-title":"Clin Transpl"},{"key":"10.1016\/j.coi.2005.07.010_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.TP.0000080685.31697.FC","article-title":"Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients","volume":"76","author":"Jordan","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib19_1","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitisation and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2005.07.010_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1399-3046.2005.00256.x","article-title":"Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection","volume":"9","author":"Jordan","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib21","first-page":"199","article-title":"Renal transplantation at the Johns Hopkins Comprehensive Transplant Center","author":"Montgomery","year":"2003","journal-title":"Clin Transpl"},{"key":"10.1016\/j.coi.2005.07.010_bib22_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3046.2004.00214.x","article-title":"Transplanting patients with a positive donor-specific crossmatch: a single center's perspective","volume":"8","author":"Montgomery","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib23_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.TP.0000129256.84027.D6","article-title":"Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols","volume":"78","author":"Montgomery","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib24","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0041-1345(02)03044-0","article-title":"Pre-emptive therapy with plasmapheresis\/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match","volume":"34","author":"Sonnenday","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.coi.2005.07.010_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199402270-00014","article-title":"Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ","volume":"57","author":"Tyan","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib26","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/S0041-1345(02)03577-7","article-title":"Auxiliary liver and combined kidney transplantation prevents hyperacute kidney rejection in highly sensitized patients","volume":"34","author":"Olausson","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.coi.2005.07.010_bib27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0041-1345(03)00621-3","article-title":"Outcome of simultaneous liver-kidney transplantation in highly sensitized, crossmatch-positive patients","volume":"35","author":"Gutierrez","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.coi.2005.07.010_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.TP.0000129257.34967.12","article-title":"Toward performing transplantation in highly sensitized patients","volume":"78","author":"Fuggle","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1984.tb01266.x","article-title":"The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease","volume":"56","author":"Bussel","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coi.2005.07.010_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00007890-199809270-00017","article-title":"Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action","volume":"66","author":"Jordan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/01.TP.0000122415.08639.53","article-title":"Intravenous immunoglobulin: a safe option for treatment of steroid-resistant rejection in the presence of infection","volume":"77","author":"Moger","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.TP.0000128194.55934.48","article-title":"Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection","volume":"78","author":"White","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1600-6135.2003.00296.x","article-title":"Successful simultaneous pancreas kidney transplantation from living-related donor against positive cross-match","volume":"4","author":"Sammartino","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 9","key":"10.1016\/j.coi.2005.07.010_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-0012.17.s9.3.x","article-title":"Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients","volume":"17","author":"Leech","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1399-0012.2004.00259.x","article-title":"Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatch","volume":"18","author":"Kayler","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.coi.2004.07.004","article-title":"Antibody, complement and accommodation in ABO-incompatible transplants","volume":"16","author":"King","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2005.07.010_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1600-6143.2004.00364.x","article-title":"Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers","volume":"4","author":"Warren","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-6143.2004.00653.x","article-title":"ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab","volume":"5","author":"Tyden","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib39","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/01.TP.0000090868.88895.E0","article-title":"Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients","volume":"76","author":"Zachary","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib40","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.transproceed.2004.07.030","article-title":"Effect of high-dose intravenous immunoglobulin on suppression of alloantibodies against HLA in highly sensitized transplant candidates","volume":"36","author":"Mahmoud","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.coi.2005.07.010_bib41","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/00007890-200105270-00014","article-title":"Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro","volume":"71","author":"Wassmuth","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1600-6143.2003.00011.x","article-title":"Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells","volume":"3","author":"Toyoda","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2249.2000.01138.x","article-title":"Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates","volume":"119","author":"Sivasai","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2005.07.010_bib44","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/01.TP.0000134974.16614.EA","article-title":"Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction","volume":"78","author":"Toyoda","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-0012.2004.00147.x","article-title":"Acute renal transplant injury and interaction between antithymocyte globulin and pooled human immunoglobulin","volume":"18","author":"Gallay","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.coi.2005.07.010_bib46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.TP.0000137199.32333.03","article-title":"Isometric tubular epithelial vacuolization in renal allograft biopsy specimens of patients receiving low-dose intravenous immunoglobulin for a positive crossmatch","volume":"78","author":"Haas","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib47_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.TP.0000128516.82593.47","article-title":"Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation","volume":"78","author":"Gloor","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.humimm.2005.01.007","article-title":"The Single Antigen expressing Lines (SALs) concept: An excellent tool for the screening for HLA specific antibodies","volume":"66","author":"Zoet","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.coi.2005.07.010_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007890-200301150-00008","article-title":"Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities","volume":"75","author":"Pei","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2005.07.010_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0198-8859(02)00382-8","article-title":"HLAMatchmaker: a molecularly based algorithm for histocompatibility determination I. Description of the algorithm","volume":"63","author":"Duquesnoy","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1016\/j.coi.2005.07.010_bib51_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.tb00379.x","article-title":"HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates","volume":"17","author":"Duquesnoy","year":"2004","journal-title":"Transpl Int"},{"key":"10.1016\/j.coi.2005.07.010_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0966-3274(94)90080-9","article-title":"Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies","volume":"2","author":"Saidman","year":"1994","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.coi.2005.07.010_bib53","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/ndt\/13.8.2027","article-title":"Sensitization to human leukocyte antigen before and after the introduction of erythropoietin","volume":"13","author":"Vella","year":"1998","journal-title":"Nephrol Dial Transplant"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791505001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791505001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:19:36Z","timestamp":1760602776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791505001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0952791505001147"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2005.07.010","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extending options for highly sensitized patients to receive a suitable kidney graft","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2005.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}